4 August 2022
Alkemy Capital Investments Plc
Grant of Options
Alkemy Capital Investments plc ("Alkemy") (LSE: ALK) is pleased to announce that further to its announcement earlier today it has granted 590,000 share options at £1 per share, for a period of 5 years, to further align Directors and senior management with shareholders.
The share options will vest one-third immediately, one-third following completion of construction finance for train 1 of TVL's processing facility in Teesside, and one-third following commissioning of train 1 of TVL's processing facility.
In addition the share options will only be exerciseable if the share price of the Company is in excess of £5 per share for 10 consecutive days.
The grant of share options to directors is set out below:
| | Options | Exercise Price | Term |
| Paul Atherley (Chairman) | 175,000 | £1.00 | 5 years |
| Sam Quinn (Director) | 140,000 | £1.00 | 5 years |
| Helen Pein (Director) | 75,000 | £1.00 | 5 years |
Further information
For further information, please visit the Company's website: www.alkemycapital.co.uk or www.teesvalleylithium.co.uk
-Ends-
| Alkemy Capital Investments Plc Sam Quinn | Tel: 0207 317 0636 |
| Buchanan Bobby Morse/Abigail Gilchrist | Tel: 0207 466 5000 TVL@buchanan.uk.com |
| VSA Capital Limited Andrew Monk (corporate broking) Andrew Raca (corporate finance) | Tel: 0203 005 5000 |
| Shard Capital Partners LLP Damon Heath
Isabella Pierre |
Tel: 0207 186 9952 Tel: 0207 186 9927 |
NOTES TO EDITORS
Alkemy is seeking to develop, construct and operate the world's leading independent and sustainable lithium hydroxide production facility.
Alkemy, through its wholly-owned subsidiary Tees Valley Lithium, has secured exclusivity to negotiate an option to lease over a 9.6ha brownfields site at the Wilton International Chemicals Park located in Teesside, a major UK Freeport.
Alkemy has completed a Class 4 Feasibility Study for its proposed lithium hydroxide facility to process feedstock imported from various sources to produce 96,000 tonnes of premium, low-carbon lithium hydroxide annually, representing around 15% of Europe's projected demand.
Forward Looking Statements
This news release contains forward‐looking information. The statements are based on reasonable assumptions and expectations of management and Alkemy provides no assurance that actual events will meet management's expectations. In certain cases, forward‐looking information may be identified by such terms as "anticipates", "believes", "could", "estimates", "expects", "may", "shall", "will", or "would". Although Alkemy believes the expectations expressed in such forward‐looking statements are based on reasonable assumptions, such statements are not guarantees of future performance and actual results or developments may differ materially from those projected. In addition, factors that could cause actual events to differ materially from the forward-looking information stated herein include any factors which affect decisions as to how to develop the project, process the materials and exercise the options in respect of the lease, which may include changes in market conditions, changes in metal prices, general economic and political conditions, environmental risks, and community and non-governmental actions. Such factors will also affect whether Alkemy will ultimately receive the benefits anticipated pursuant to relevant agreements. This list is not exhaustive of the factors that may affect any of the forward‐looking statements. These and other factors should be considered carefully and readers should not place undue reliance on forward-looking information.
The Notification of Dealing Form provided in accordance with the requirements of the Market Abuse Regulation in relation to the transaction listed above is set out below.
| 1
| Details of the person discharging managerial responsibilities / person closely associated
| ||||
| a)
| Name
| 1. Paul Atherley 2. Sam Quinn 3. Helen Pein
| |||
| 2
| Reason for the notification | ||||
| a)
| Position/status
| 1. Chairman 2. Director 3. Director
| |||
| b)
| Initial notification /Amendment
| Intial Notification | |||
| 3
| Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
| ||||
| a)
| Name
| Alkemy Capital Investments PLC | |||
| b)
| LEI
| 213800NW5GVIRMXSRL48 | |||
| 4
| Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
| ||||
| a)
| Description of the financial instrument, type of instrument | Ordinary shares | |||
| | | ||||
| Identification code | GB00BMD6C023 | ||||
| | | ||||
| b)
| Nature of the transaction
| Grant of Share Options subject to vesting conditions and only be exerciseable if the share price of the Company's ordinary shares is in excess of £5 per share for 10 consecutive days. | |||
| c)
| Price(s) and volume(s) | | | | |
| | | Excersie Price(s) | Volume(s) | | |
| | | 1. 1.00 2. 1.00 3. 1.00
| 175,000 140,000 75,000
| | |
| | | | | | |
| d)
| Aggregated information | | |||
| | | ||||
| - Aggregated volume | N/A | ||||
| | | ||||
| - Price | £1.00 | ||||
| | | ||||
| e)
| Date of the transaction
| 03/08/2022 | |||
| f)
| Place of the transaction
| Outside a trading venue | |||
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.